ANNA RODIS: Open Payments
NPI 1700534401 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$361 in 27 payments from 8 companies in 2025. Trend: 2023 $505 · 2024 $564 · 2025 $361
Food & beverage: $361
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $183 |
| Amgen Inc. | 2 | $46 |
| PFIZER INC. | 2 | $34 |
| Exact Sciences Corporation | 1 | $24 |
| Eisai Inc. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: UBRELVY, VRAYLAR, NURTEC ODT, Cologuard Collection Kit, KRYSTEXXA, Leqembi, QULIPTA, OTEZLA.
Industry payments across PA — which companies pay providers there.
